Early Age-Related Hearing Loss Investigation (EARHLI) (Dementia)
Sponsor: |
NIH |
Enrolling: |
Male and Female Patients |
Clinic Visits: |
7 |
IRB Number: |
AAAU1896 |
U.S. Govt. ID: |
NCT06174038 |
Contact: |
Michael Gomez: 646-317-3252 / earhli@cumc.columbia.edu |
Early Age-Related Hearing Loss Investigation (EARHLI) is a study to obtain information on how a hearing aid-based intervention can prevent cognitive decline in those at risk for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD). Age-related hearing loss (ARHL) is the third most common chronic condition in older adults. The way Age-related hearing loss (ARHL) and Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) are linked are unknown but reduced social engagement and changes in brain organization/connectivity have been proposed. This study will focus on early Age-related hearing loss (ARHL) in middle and early older age, a critical time for the development of Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) and an ideal time to intervene. Medical experts have proposed that eliminating Age-related hearing loss (ARHL) would be associated with an 8% reduction in new dementia cases. Yet, 90% of our target population is not treated with hearing aids and there is a lack of studies testing the efficacy of hearing aids in Age-related hearing loss (ARHL). Moreover, while studies have suggested that hearing aids improve cognition, social engagement, and brain organization/connectivity there is still no concrete evidence. The goal of this study is to address these knowledge gaps.
Investigator
Justin Golub, MD, MS
Are you or your family member between the ages of 55-75? |
Yes |
No |
Do you or your family member have adult-onset hearing loss? |
Yes |
No |
Do you or your family member have mild memory problems? |
Yes |
No |
Are you or your family member fluent in English or Spanish? |
Yes |
No |